{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T06:45:21Z","timestamp":1774075521576,"version":"3.50.1"},"reference-count":30,"publisher":"Japanese Society of Internal Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,3,15]]},"DOI":"10.2169\/internalmedicine.5860-25","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T22:07:30Z","timestamp":1755122850000},"page":"774-781","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Controlled Blood Pressure and Pulse Rate at Discharge on Clinical Outcomes in Patients with Non-ST-segment Elevation Myocardial Infarction"],"prefix":"10.2169","volume":"65","author":[{"given":"Yuya","family":"Watanabe","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Sakakura","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Jinnouchi","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yousuke","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takunori","family":"Tsukui","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Hatori","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Seguchi","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taku","family":"Kasahara","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun","family":"Ishibashi","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Fujita","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385: 117-171, 2015.","DOI":"10.1016\/S0140-6736(14)61682-2"},{"key":"2","unstructured":"2. Braunwald E, Antman EM, Beasley JW, et al. ACC\/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 36: 970-1062, 2000."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Hoshi T, Sawano M, Kohsaka S, et al. Impact of sex differences on clinical outcomes in patients following primary revascularization for acute myocardial infarction - insights from the Japanese nationwide registry. Circ J 88: 1211-1222, 2024.","DOI":"10.1253\/circj.CJ-23-0966"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Takeji Y, Shiomi H, Morimoto T, et al. Differences in mortality and causes of death between STEMI and NSTEMI in the early and late phases after acute myocardial infarction. PLoS One 16: e0259268, 2021.","DOI":"10.1371\/journal.pone.0259268"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. F Ragmin and Fast Revascularisation during InStability in Coronary artery disease Investigators. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. Lancet 354: 708-715, 1999.","DOI":"10.1016\/S0140-6736(99)07349-3"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Bhatt DL, Lopes RD, Harrington RA. Diagnosis and treatment of acute coronary syndromes: a review. Jama 327: 662-675, 2022.","DOI":"10.1001\/jama.2022.0358"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Hoedemaker NPG, Damman P, Ottervanger JP, et al. Trends in optimal medical therapy prescription and mortality after admission for acute coronary syndrome: a 9-year experience in a real-world setting. Eur Heart J Cardiovasc Pharmacother 4: 102-110, 2018.","DOI":"10.1093\/ehjcvp\/pvy005"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Miller CD, Roe MT, Mulgund J, et al. Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction. Am J Med 120: 685-692, 2007.","DOI":"10.1016\/j.amjmed.2007.04.016"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kurobe M, Baba K, Nunohiro T, et al. Impact of implementation of a region-wide low-density lipoprotein cholesterol management clinical pathway for the secondary prevention of acute myocardial infarction. Circ J 88: 1825-1832, 2024.","DOI":"10.1253\/circj.CJ-24-0338"},{"key":"10","unstructured":"10. Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 79: 1757-1780, 2022."},{"key":"11","unstructured":"11. Rao SV, O'Donoghue ML, Ruel M, et al. 2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 151: e771-e862, 2025."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Umemura S, Arima H, Arima S, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertens Res 42: 1235-1481, 2019.","DOI":"10.1038\/s41440-019-0284-9"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Thygesen K, Alpert JS, Jaffe AS, et al. Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol 72: 2231-2264, 2018.","DOI":"10.1016\/j.jacc.2018.08.1038"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Murakami T, Sakakura K, Taniguchi Y, et al. Comparison of the cost in percutaneous coronary intervention between ST-segment elevation myocardial infarction vs. non-ST-segment elevation myocardial infarction. Cardiovasc Interv Ther 37: 293-303, 2022.","DOI":"10.1007\/s12928-021-00778-3"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ishibashi S, Sakakura K, Asada S, et al. Association of collateral flow with clinical outcomes in patients with acute myocardial infarction. Heart Vessels 37: 1496-1505, 2022.","DOI":"10.1007\/s00380-022-02054-7"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ohashi J, Sakakura K, Sasaki W, et al. Usefulness of 500-m walk electrocardiogram test on clinical outcomes in patients with ST-segment elevation myocardial infarction. Heart Vessels 36: 48-57, 2021.","DOI":"10.1007\/s00380-020-01667-0"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Raisi-Estabragh Z, Cooper J, Judge R, et al. Age, sex and disease-specific associations between resting heart rate and cardiovascular mortality in the UK BIOBANK. PLoS One 15: e0233898, 2020.","DOI":"10.1371\/journal.pone.0233898"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kang HB, Choi M, Yoon SG, Cho YS, Je NK. In-hospital prescriptions of secondary-prevention medications for post-acute coronary syndrome patients in South Korea. Int J Clin Pharmacol Ther 56: 1-11, 2018.","DOI":"10.5414\/CP202986"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Lee HY, Cooke CE, Robertson TA. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge. J Manag Care Pharm 14: 271-280, 2008.","DOI":"10.18553\/jmcp.2008.14.3.271"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. El-Hajj MS, Saad A, Al-Suwaidi J, et al. Utilization of evidence-based secondary prevention medications at the time of discharge in patients with acute coronary syndrome (ACS) in Qatar. Curr Vasc Pharmacol 14: 394-403, 2016.","DOI":"10.2174\/1570161114666160226150336"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Mouhat B, Putot A, Hanon O, et al. Low Systolic Blood Pressure and Mortality in Elderly Patients After Acute Myocardial Infarction. J Am Heart Assoc 9: e013030, 2020.","DOI":"10.1161\/JAHA.119.013030"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Kobayashi S, Sakakura K, Jinnouchi H, et al. Impact of controlled blood pressure and pulse rate at discharge on clinical outcomes in patients with ST-segment elevation myocardial infarction. J Cardiol 83: 394-400, 2024.","DOI":"10.1016\/j.jjcc.2023.09.013"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Wright JT Jr., Williamson JD, Whelton PK, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 373: 2103-2116, 2015.","DOI":"10.1056\/NEJMoa1511939"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Lewis CE, Fine LJ, Beddhu S, et al. Final report of a trial of intensive versus standard blood-pressure control. N Engl J Med 384: 1921-1930, 2021.","DOI":"10.1056\/NEJMoa1901281"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. M\u00fcller-Werdan U, St\u00f6ckl G, Werdan K. Advances in the management of heart failure: the role of ivabradine. Vasc Health Risk Manag 12: 453-470, 2016.","DOI":"10.2147\/VHRM.S90383"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Ferrari R, Fox K. Heart rate reduction in coronary artery disease and heart failure. Nat Rev Cardiol 13: 493-501, 2016.","DOI":"10.1038\/nrcardio.2016.84"},{"key":"27","doi-asserted-by":"crossref","first-page":"I344","DOI":"10.1161\/CIRCULATIONAHA.105.000463","volume":"114","author":"HH Feringa","year":"2006","unstructured":"27. Feringa HH, Bax JJ, Boersma E, et al. High-dose beta-blockers and tight heart rate control reduce myocardial ischemia and troponin T release in vascular surgery patients. Circulation 114: I344-I349, 2006.","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28. Andrews TC, Fenton T, Toyosaki N, et al. Subsets of ambulatory myocardial ischemia based on heart rate activity. Circadian distribution and response to anti-ischemic medication. The Angina and Silent Ischemia Study Group (ASIS). Circulation 88: 92-100, 1993.","DOI":"10.1161\/01.CIR.88.1.92"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Pratt CM, McMahon RP, Goldstein S, et al. Comparison of subgroups assigned to medical regimens used to suppress cardiac ischemia (the Asymptomatic Cardiac Ischemia Pilot [ACIP] study). Am J Cardiol 77: 1302-1309, 1996.","DOI":"10.1016\/S0002-9149(96)00196-8"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Ishihara M, Nakao K, Ozaki Y, et al. Long-term outcomes of non-ST-elevation myocardial infarction without creatine kinase elevation - the J-MINUET study. Circ J 81: 958-965, 2017.","DOI":"10.1253\/circj.CJ-17-0033"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/6\/65_5860-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T03:33:32Z","timestamp":1774064012000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/6\/65_5860-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,15]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5860-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,15]]},"article-number":"5860-25"}}